MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosisJinho Jung, Rohan Loomba, Kento Imajo et al.|Gut|2020Cited by 155
Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLDBeom Kyung Kim, Rohit Loomba, Jaclyn Bergstrom et al.|Journal of Hepatology|2022Cited by 105
Prevalence of pruritus in patients with chronic liver disease: A multicenter studySatoshi Oeda, Hirokazu Takahashi, Hisako Yoshida et al.|Hepatology Research|2017Cited by 63
Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter surveyKatsutoshi Tokushige, Etsuko Hashimoto, Hideyuki Hyogo et al.|Journal of Gastroenterology|2015Cited by 61
Gut microbiota composition associated with hepatic fibrosis in non‐obese patients with non‐alcoholic fatty liver diseaseMichihiro Iwaki, Atsushi Nakajima, Takaomi Kessoku et al.|Journal of Gastroenterology and Hepatology|2021Cited by 44